Explore Our Range of Amyloid Beta Peptides
We offer a wide selection of Amyloid Beta Peptides that cater to various research needs. Whether you are conducting biochemical assays, investigating neuronal toxicity, or studying plaque formation, our products deliver unparalleled quality and reliability. Find our Amyloid Beta Peptides here:
What are Amyloid Beta Peptides?
The Role of Amyloid Beta Protein in Alzheimer’s Disease
The Amyloid Beta Peptide consists of 36-43 amino acids cleaved from the precursor protein APP. Misfolding and aggregation of these peptides into soluble oligomers are considered the primary pathological mechanism in Alzheimer’s disease. These Amyloid Beta Proteins can induce neighboring molecules to misfold, initiating a chain reaction similar to prion-like activity, leading to neuron toxicity and brain cell death. Key Features of Amyloid Beta Peptides: Derived from Amyloid Beta Precursor Protein (APP). 36-43 amino acids in length. Known for forming plaques in Alzheimer's patients. Forms toxic oligomers when misfolded.
Key Features of Amyloid Beta Peptides:
- Derived from Amyloid Beta Precursor Protein (APP).
- 36-43 amino acids in length.
- Known for forming plaques in Alzheimer's patients.
- Forms toxic oligomers when misfolded.
Why Choose Our Amyloid Beta Peptides for Your Research?
Our Amyloid Beta Peptides are synthesized with high precision to ensure they meet the stringent standards required for neurological and biochemical research. Whether you are investigating plaque formation, prion-like behavior of oligomers, or potential therapeutic interventions, our products offer the purity and consistency necessary for accurate results.
Product Highlights:
- Available in multiple lengths, including full-length Amyloid Beta (1-42) and truncated forms.
- Ideal for Alzheimer's disease research, toxicity assays, and protein misfolding studies.
- Rigorous quality control for reliable aggregation behavior and misfolding characteristics.
Applications of Amyloid Beta Proteins in Research and Development
Advancing Alzheimer's Research with Amyloid Beta Protein
Amyloid Beta Proteins are central to the study of Alzheimer’s, from identifying early-stage oligomer formations to screening potential therapeutic compounds. By providing high-quality peptides, we empower researchers to further their understanding of the mechanisms behind the disease and develop potential treatments targeting these protein aggregates.
Research Areas for Amyloid Beta Peptides:
- Alzheimer’s disease mechanisms.
- Protein misfolding and aggregation.
- Therapeutic development and drug screening.
- Neurotoxicity studies.
Optimized Amyloid Beta Peptides for Cutting-Edge Research
In Alzheimer's research, using the right tools can make all the difference. Our Amyloid Beta Peptides and Amyloid Beta Proteins are manufactured to the highest standards to support groundbreaking research and therapeutic discovery. Contact us today, our specialized support team will provide you with any information or help you need.